The DOI matches its Crossref record; 51 of the 55 references it cites were found in a registry or an index; 12 of the 57 sources its claims cite were checked for support.
Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test
Open accessAbstract
Context: Adrenal insufficiency (AI) is usually diagnosed by low plasma cortisol levels following a short Synacthen test (SST). Most plasma cortisol is bound to corticosteroid-binding globulin, which is increased by estrogen in combined estrogen-progestin oral contraceptives (COCs). Women with AI using COCs are therefore at risk of having an apparently normal plasma cortisol level during SST, which would not adequately reflect AI. Objective: This work aimed to test whether salivary cortisol or cortisone during SST is more robust against the COC effect and to calculate the lower reference limits (LRLs) for these to be used as tentative diagnostic cutoffs to exclude AI. Methods: Forty-one healthy women on COCs and 46 healthy women without exogenous estrogens underwent an SST with collection of plasma and salivary samples at 0, 30, and 60 minutes after Synacthen injection. The groups were compared using regression analysis with age as covariate and the LRLs were calculated parametrically. Results: SST-stimulated plasma cortisol levels were significantly higher in the COC group vs controls, while mean salivary cortisol and cortisone levels were slightly lower in the COC group. Importantly, COC use did not significantly alter LRLs for salivary cortisol or cortisone. The smallest LRL difference between groups was seen for salivary cortisone. Conclusion: Salivary cortisol and especially salivary cortisone are considerably less affected by COC use than plasma cortisol during SST. Due to similar LRLs, a common cutoff for salivary cortisol and cortisone during SST can be used to exclude AI in premenopausal women irrespective of COC use.
Overview
CoChat Summary
TL;DR
In healthy women undergoing a short Synacthen test (SST), salivary cortisol and especially salivary cortisone were much less affected by combined oral contraceptive (COC) use than plasma cortisol. The authors propose common salivary cutoffs to exclude adrenal insufficiency irrespective of COC use.
Key findings
- Plasma cortisol after SST was significantly higher in COC users than controls at baseline (910 vs 360 nmol/L), 30 min (1180 vs 620 nmol/L), and 60 min (1310 vs 707 nmol/L; all P < .001).
- Salivary cortisol and cortisone were slightly lower in COC users at 30 and 60 min; e.g., salivary cortisol at 60 min was 43.2 vs 48.4 nmol/L (P = .011), and salivary cortisone at 60 min was 78.0 vs 83.8 nmol/L (P = .035).
- Lower reference limits (LRLs) for salivary cortisol and cortisone did not differ significantly between COC users and controls by bootstrap simulation. At 60 min, salivary cortisone LRLs were 48.1 vs 48.8 nmol/L, while plasma cortisol LRLs were 870 vs 566 nmol/L.
- The authors suggest salivary cortisone above 37 nmol/L at 30 min or above 49 nmol/L at 60 min, and salivary cortisol above 17 nmol/L at 30 min or above 26 nmol/L at 60 min, are likely to exclude adrenal insufficiency regardless of COC use.
Methods
- Prospective study of 89 recruited healthy women aged 18–50; after exclusions, 41 women using monophasic ethinylestradiol-containing COCs and 46 nonusers of estrogens underwent a standard SST with 250 µg Synacthen.
- Plasma and salivary samples were collected at 0, 30, and 60 min. Plasma cortisol was measured by Roche Elecsys Cortisol II; salivary cortisol and cortisone were measured by LC-MS/MS.
- Groups were compared using regression with age as covariate; LRLs were calculated parametrically using the UMVUE method, with bootstrap simulation to test differences between LRLs.
Limitations
- The paper states that the study had a limited number of observations, that diagnostic accuracy in patients with suspected adrenal insufficiency still needs evaluation, and that the cutoffs cannot immediately be extrapolated to other analytical methods, pregnancy, low-CBG states, postmenopausal women, or men.
- The paper notes that the age-related decrease in cortisol measures was unexpected and warrants further study, and that progestin-type findings were based on low numbers and should be interpreted cautiously.
- Evident from the text: participants were healthy women, not patients with adrenal insufficiency, so sensitivity and specificity of the proposed salivary cutoffs were not directly assessed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
7 Valid · 1 Not valid · 12 Not checked · 50 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“However, an increased amount of corticosteroid-binding globulin (CBG) entails a risk for misleadingly normal total plasma cortisol levels as more CBG-bound cortisol will be measured, even though cortisol release and free, biologically active cortisol levels may be low (5-9).”
§ Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test > Abstract > Conclusion
What the sources say
- Not checked — no full text of the sourcecites [5] Charmandari, 2014, Adrenal insufficiency, Lancet source
- Not checked — no full text of the sourcecites [6] Musa, 1965, Elevation of certain plasma proteins in man following estrogen administration: a dose-response relationship, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [7] El-Farhan, 2013, Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays, Clin Endocrinol (Oxf) source
- Disputedcites [8] Hawley, 2016, Serum cortisol: an up-to-date assessment of routine assay performance, Clin Chem sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) links increased CBG in pregnant patients to immunoassay underrecovery of cortisol: the assays may fail to release and measure all CBG-bound cortisol. That is contrary to the attributed explanation that increased CBG causes more bound cortisol to be measured, producing misleadingly normal total levels. The paper does not assess whether free cortisol is low in that situation. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [9] Meulenberg, 1987, The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone, Clin Chim Acta source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Salivary cortisone may have an advantage over salivary cortisol as a diagnostic analyte, since it is considerably more robust against confounding factors including blood contamination, topical hydrocortisone, and licorice consumption (23, 27).”
§ Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test > Discussion
What the sources say
- Not checked — no full text of the sourcecites [23] Bäcklund, 2020, Reference intervals of salivary cortisol and cortisone and their diagnostic accuracy in Cushing's syndrome, Eur J Endocrinol source
- Supportedcites [27] Imamovic, 2022, Confounding effects of liquorice, hydrocortisone, and blood contamination on salivary cortisol but not cortisone, Endocr Connect source
The Discussion concludes that salivary cortisol may be falsely elevated by liquorice, blood contamination, and topical hydrocortisone, while salivary cortisone is essentially unaffected by these confounders. It proposes cortisone as a more robust screening instrument for Cushing’s syndrome; the topical-hydrocortisone experiment did show a slight cortisone increase, rather than no effect. (LLM, conf=0.95)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Elevated CBG levels are typically seen in hyperestrogenemic states such as pregnancy and with the use of estrogen/progestin-containing combined oral contraceptives (COCs) (10-12).”
§ Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test > Abstract > Conclusion
What the sources say
- Partly supportedcites [10] Sandberg, 1959, Transcortin: a corticosteroid-binding protein of plasma. II. Levels in various conditions and the effects of estrogens, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports increased transcortin binding capacity during pregnancy, and the section on estrogen administration reports increased transcortin levels after estrogen treatment. The paper does not address estrogen/progestin-containing combined oral contraceptives specifically, so it does not establish that part of the claim. (LLM, conf=0.88)
- Supportedcites [11] Kawagoe, 1978, Effects of several estrogenic compounds on serum corticosteroid-binding globulin (CBG) and the estrogen thresholds for increasing CBG, Nihon Naibunpi Gakkai Zasshi source
The English Abstract (p. 1) reports that Ovral, which contains ethinylestradiol and norgestrel, induced significant increases in CBG-BC (with similar but smaller effects for Lo Ovral), and that in pregnant women serum CBG-BC rose once estradiol exceeded 1 ng/ml. The Discussion (第54巻 第5号, p. 6) states plainly that human CBG is known to rise markedly during pregnancy and on estrogen administration, and the results section lists OrthoNovum 1/50, OrthoNovum 1/80, Ovral and Lo Ovral among the preparations that raised CBG-BC (p. 5). Both instances the claim attributes to this source — pregnancy and estrogen/progestin combined oral contraceptives — are therefore stated in our copy; the only qualification the paper adds is its threshold concept (norgestrel alone had no effect, and CBG rose only above ~1 ng/ml estradiol), which does not contradict the claim as phrased. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [12] Moore, 1978, An in vivo system in man for quantitation of estrogenicity. I. Physiologic changes in binding capacity of serum corticosteroid-binding globulin, Am J Obstet Gynecol source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The validity of our calculated LRLs for salivary cortisol and cortisone is strengthened by the similarities to previously published cutoffs (25, 30, 36, 42).”
§ Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test > Discussion
What the sources say
- Not checked — no full text of the sourcecites [25] Cornes, 2015, Salivary cortisol and cortisone responses to tetracosactrin (synacthen), Ann Clin Biochem source
- Partly supportedcites [30] Dušková, 2016, A comparison of salivary steroid levels during diagnostic tests for adrenal insufficiency, Prague Med Rep sourceExperimental — accuracy not yet measured
The Results report stimulated salivary cortisol and cortisone levels in healthy participants, including values above 12.5 and 27.8 nmol/L during the insulin tolerance test. The paper does not designate these values as calculated lower reference limits or compare them with the citing authors’ limits, so the claimed similarity to published cutoffs is not established by this source alone. (LLM, conf=0.78)
- Not checked — no full text of the sourcecites [36] Deutschbein, 2009, Diagnosis of secondary adrenal insufficiency in patients with hypothalamic-pituitary disease: comparison between serum and salivary cortisol during the high-dose short synacthen test, Eur J Endocrinol source
- Not checked — no full text of the sourcecites [42] Kalaria, 2020, Hypothalamic-pituitary-adrenal axis suppression: the value of salivary cortisol and cortisone in assessing hypothalamic-pituitary-adrenal recovery, Ann Clin Biochem source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It has previously been shown that salivary samples can be used during the short Synacthen test (SST) in the diagnostic work-up for AI (29-34).”
§ Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test > Abstract > Conclusion
What the sources say
- Not checked — no full text of the sourcecites [29] Aardal-Eriksson, 1998, Salivary cortisol: an alternative to serum cortisol determinations in dynamic function tests, Clin Chem Lab Med source
- Partly supportedcites [30] Dušková, 2016, A comparison of salivary steroid levels during diagnostic tests for adrenal insufficiency, Prague Med Rep sourceExperimental — accuracy not yet measured
The Methods and Results describe collecting saliva during Synacthen tests and measuring a salivary cortisol response. The Discussion says salivary cortisol behaved similarly to serum cortisol, supporting its potential use during testing. But the study included only healthy men, so it did not establish that salivary sampling works in the diagnostic work-up of patients with suspected adrenal insufficiency; the indexed passages provide no page numbers. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [31] Perogamvros, 2010, Measurement of salivary cortisol with liquid chromatography-tandem mass spectrometry in patients undergoing dynamic endocrine testing, Clin Endocrinol source
- Not checked — no full text of the sourcecites [32] Marcus-Perlman, 2006, Low-dose ACTH (1 µg) salivary test: a potential alternative to the classical blood test, Clin Endocrinol (Oxf) source
- Not checked — no full text of the sourcecites [33] Raff, 2009, Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency, J Clin Endocrinol Metab source
- Supportedcites [34] Tan, 2023, Expanding the use of salivary cortisol as a non-invasive outpatient test in the dynamic evaluation of suspected adrenal insufficiency, Endocr Connect source
The Methods (ACTH stimulation test) describe collecting saliva at baseline and at 30 and 60 minutes after Synacthen administration in patients evaluated for adrenal insufficiency. The Abstract conclusion states that salivary cortisol during the 250 µg Synacthen test can be used to diagnose adrenal insufficiency. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
44 more claims
Create a free account to see all 70 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 13
- Probably not a substantial claim. 11
Citations
Cites
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
Charmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Premature Mortality in Patients with Addison’s Disease: A Population-Based Study
Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0076 · Cited by 490 · cited 1×
“Adrenal insufficiency (AI) is a rare condition causing substantial morbidity, increased mortality, and risk of fatal acute adrenal crises (1-3).”
BackgroundSalivary cortisol measurement: a practical approach to assess pituitary-adrenal function.
LAUDAT, M. H., CERDAS, S., FOURNIER, C., GUIBAN, D., GUILHAUME, B., & LUTON, J. P. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-343 · Cited by 393
A rapid test of adrenocortical function
Wood, J. B., James, V. H. T., Frankland, A. W., & Landon, J. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91526-6 · Cited by 312 · cited 1×
“Low plasma cortisol in a Synacthen test is diagnostic for AI (4).”
BackgroundUrinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in man
Palermo, M., Shackleton, C. H. L., Mantero, F., & Stewart, P. M. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00853.x · Cited by 276 · cited 1×
“The present study and previous data show higher salivary cortisol:cortisone ratios with increasing concentrations, indicating that higher levels of cortisol overwhelm the capacity of 11 β -HSD2 in the salivary glands (23, 47).”
ResultSandberg, A. A., & Slaunwhite, W. R. (1959) · Journal of Clinical Investigation · doi:10.1172/jci103904 · Cited by 235 · cited 1×
“Elevated CBG levels are typically seen in hyperestrogenemic states such as pregnancy and with the use of estrogen/progestin-containing combined oral contraceptives (COCs) (10-12).”
BackgroundSalivary cortisone is a potential biomarker for serum free cortisol
Perogamvros, I., Keevil, B. G., Ray, D. W., & Trainer, P. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1215 · Cited by 222 · cited 2×
“Salivary cortisone has been shown to correlate better with plasma free cortisol than salivary cortisol and to be less susceptible to preanalytical confounders (20, 23, 27, 28).”
BackgroundMethodUtility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency
Raff, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1166 · Cited by 186
Burman, P., Mattsson, A. F., Johannsson, G., Höybye, C., Holmer, H., Dahlqvist, P., Berinder, K., Engström, B. E., Ekman, B., Erfurth, E. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4059 · Cited by 184
Self-citation
Research works printed but not linked: 1
- Horowitz, 2010, Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline—Third Edition
Cited by
Cortisol: Biosensing and detection strategies
Balasamy, S., Atchudan, R., Arya, S. K., Gunasekaran, B. M., Nesakumar, N., & Sundramoorthy, A. K. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119888 · Cited by 52
Utility of Salivary Cortisol and Cortisone in the Diagnostics of Adrenal Insufficiency
Hellan, K. K., Lyngstad, M., Methlie, P., Løvås, K., Husebye, E. S., & Ueland, G. Å. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae486 · Cited by 13
Do, M., Hayes, A. G., & Brzozowska, M. M. (2025) · The Medical Journal of Australia · doi:10.5694/mja2.52647 · Cited by 7
Neoplastic hypercortisolism: Cut-off values for late-night salivary cortisol & cortisone
Koops, K., Bisschop, P. H. L. T., Heijboer, A. C., & Hillebrand, J. J. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120310 · Cited by 3
Heald, A. H., Mordaunt, M., Gallant, N., Baker, H., Majeed, W., Kochhar, R. S., Syed, A. A., Mudaliar, R. N., Abushufa, R., Hanna, F., et al. (2025) · Clinical Endocrinology · doi:10.1111/cen.15279 · Cited by 4
“…measurement is that the level of salivary cortisone is not influenced by the levels of cortisol binding globulin, so estrogen containing preparations in the form of the combined oral contraceptive pill (COCP) and hormone replacement treatment do not have to stopped 1 month before the test [17, 18].”
Metadata
- Authors
- Bäcklund, N., Lundstedt, S., Tornevi, A., Wihlbäck, A.-C., Olsson, T., Dahlqvist, P., & Brattsand, G.
- Affiliations
- Umeå University (SE)
- Corresponding author
- Bäcklund, Nils
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2024-01-04
- Volume
- 109
- Issue
- 7
- Pages
- 1899-1906
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC11180507
- OpenAlex
- W4390584301
- Semantic Scholar
- 984841e49eef42e94e5f699204d271886ea0079b
- Cited by
- 13
- References
- 55
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 4
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DiVA at Umeå University (Umeå University) (submittedVersion, other-oa)
- Funders
- Västerbotten County Council
- Umeå University
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Keywords
- adrenal insufficiency, ACTH stimulation test, salivary cortisol, salivary cortisone, oral contraceptives, corticosteroid-binding globulin, estrogen, diagnostic thresholds, premenopausal women, confounding
- MeSH terms
- Adrenal Insufficiency, Adult, Contraceptives, Oral, Contraceptives, Oral, Combined, Cortisone, Cosyntropin, Female, Humans, Hydrocortisone, Reference Values, Saliva, Case-Control Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test. https://app.cochat.ai/papers/10.1210/clinem/dgad763
- The paper
- Bäcklund, N., Lundstedt, S., Tornevi, A., Wihlbäck, A.-C., Olsson, T., Dahlqvist, P., & Brattsand, G. (2024). Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad763
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.